Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises M2J Holding in conjunction with the sale of Seliro with its subsidiary Tilgin to Inteno Group
Mandate

Vinge advises M2J Holding in conjunction with the sale of Seliro with its subsidiary Tilgin to Inteno Group

June 10, 2021 M&A

Inteno Group develops technology which creates conditions for the continuously connected home, with a customer base of 600 business to business customers in Europe and Asia.

During the last 10 years, the company has enjoyed an annual increase (CAGR) of 20% and is expected to reach a turnover of SEK 1 billion during 2022.

Vinge’s team primarily consisted of Henrik Borna, Daniel Daun, Lena Westberg and Viktoria Owetz Leyva.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024